500 mg · vegan · gluten-free · 90 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Devil's Claw, standardized for its active compound harpagoside, is a botanical extract traditionally used for managing joint and back discomfort. It is formulated in capsule form for adult use, offering a targeted, single-ingredient approach to musculoskeletal support.
Harpagoside, the primary active constituent, exerts anti-inflammatory effects by inhibiting key inflammatory mediators like TNF-alpha and COX-2 enzymes. This mechanism helps to reduce pain and improve joint mobility, with noticeable effects typically observed within 4-12 weeks of consistent use.
Adults looking to address joint stiffness, muscle weakness, joint pain. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
B · B · emerging-to-moderate human evidence for joint and musculoskeletal health
SacredBod's longer take on Devil's Claw (Harpagoside) — context the structured blocks above don't capture.
Devil’s Claw (Harpagoside) is a natural pain management supplement used to support joint and musculoskeletal health. Harpagophytum root for back and joint pain. It is available in capsule form and dosed for adults in India and internationally. As a western-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. Devil’s Claw (Harpagoside) works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the joints, muscles, bones, and effects are dose-dependent, typically becoming measurable within 4-12 weeks for joint comfort. Consistency matters more than dose size for this category.
Devil’s Claw (Harpagoside) carries an evidence grade of B in the SacredBod catalog, reflecting good-but-limited human evidence for joint and musculoskeletal health. Harpagophytum root for back and joint pain. Benefits are cumulative rather than immediate, typically becoming noticeable within 4-12 weeks for joint comfort, and individual response varies.
A typical dose is 500 mg, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Adults looking to address joint stiffness, muscle weakness, joint pain. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Natural Pain Management category, Devil’s Claw (Harpagoside) can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
Request received.
We'll route this to a clinician familiar with peptide protocols. Expect a reply within about 48 hours.
How's your experience? We read every note.
